Gelber, Richard D.

Dellapasqua, Silvia; Gray, Kathryn P.; Munzone, Elisabetta; Rubino, Daniela; Gianni, Lorenzo; Johansson, Harriet; Viale, Giuseppe; Ribi, Karin; Bernhard, Jürg; Kammler, Roswitha; Maibach, Rudolf; Rabaglio, Manuela; Ruepp, Barbara; Di Leo, Angelo; Coates, Alan S.; Gelber, Richard D.; Regan, Meredith M.; Goldhirsch, Aron; Colleoni, Marco (2019). Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial. Journal of clinical oncology, 37(5), pp. 386-395. American Society of Clinical Oncology 10.1200/JCO.18.00296

Wapnir, Irene L.; Price, Karen N.; Anderson, Stewart J.; Robidoux, André; Martín, Miguel; Nortier, Johan W.R.; Paterson, Alexander H.G.; Rimawi, Mothaffar F.; Láng, István; Baena-Cañada, José Manuel; Thürlimann, Beat; Mamounas, Eleftherios P.; Geyer, Charles E.; Gelber, Shari; Coates, Alan S.; Gelber, Richard D.; Rastogi, Priya; Regan, Meredith M.; Wolmark, Norman and Aebi, Stefan (2018). Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial. Journal of clinical oncology, 36(11), pp. 1073-1079. American Society of Clinical Oncology 10.1200/JCO.2017.76.5719

Decensi, Andrea; Sun, Zhuoxin; Guerrieri-Gonzaga, Aliana; Thürlimann, Beat; McIntosh, Christina; Tondini, Carlo; Monnier, Alain; Campone, Mario; Debled, Marc; Schönenberger, Astrid; Zaman, Khalil; Johansson, Harriet; Price, Karen N; Gelber, Richard D.; Goldhirsch, Aron; Coates, Alan S.; Aebi, Stefan (2014). Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences. Breast cancer research and treatment, 144(2), pp. 321-329. Springer 10.1007/s10549-014-2849-2

Aebi, Stefan; Gelber, Shari; Anderson, Stewart J.; Láng, István; Robidoux, André; Martín, Miguel; Nortier, Johan W. R.; Paterson, Alexander H. G.; Rimawi, Mothaffar F.; Cañada, José Manuel Baena; Thürlimann, Beat; Murray, Elizabeth; Mamounas, Eleftherios P.; Geyer, Charles E.; Price, Karen N.; Coates, Alan S.; Gelber, Richard D.; Rastogi, Priya; Wolmark, Norman and Wapnir, Irene L. (2014). Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial. The lancet oncology, 15(2), pp. 156-163. Elsevier 10.1016/S1470-2045(13)70589-8

Goldhirsch, Aron; Gelber, Richard D.; Piccart-Gebhart, Martine J.; de Azambuja, Evandro; Procter, Marion; Suter, Thomas; Jackisch, Christian; Cameron, David; Weber, Harald A.; Heinzmann, Dominik; Dal Lago, Lissandra; McFadden, Eleanor; Dowsett, Mitch; Untch, Michael; Gianni, Luca; Bell, Richard; Köhne, Claus-Henning; Vindevoghel, Anita; Andersson, Michael; Brunt, A Murray; ... (2013). 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial. Lancet, 382(9897), pp. 1021-1028. Elsevier 10.1016/S0140-6736(13)61094-6

Crivellari, Diana; Gray, Kathryn P.; Dellapasqua, Silvia; Puglisi, Fabio; Ribi, Karin; Price, Karen N.; Láng, István; Gianni, Lorenzo; Spazzapan, Simon; Pinotti, Graziella; Lüthi, Jean-Marc; Gelber, Richard D.; Regan, Meredith M; Colleoni, Marco; Castiglione-Gertsch, Monica; Maibach, Rudolf; Rabaglio, Manuela; Coates, Alan S.; Goldhirsch, Aron (2013). Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial. Breast, 22(2), pp. 130-137. Elsevier 10.1016/j.breast.2013.01.015

Regan, Meredith M.; Leyland-Jones, Brian; Bouzyk, Mark; Pagani, Olivia; Tang, Weining; Kammler, Roswitha; Dell’Orto, Patrizia; Biasi, Maria Olivia; Thürlimann, Beat; Lyng, Maria B.; Ditzel, Henrik J.; Neven, Patrick; Debled, Marc; Maibach, Rudolf; Price, Karen N.; Gelber, Richard D.; Coates, Alan S.; Goldhirsch, Aron; Rae, James M. and Viale, Giuseppe (2012). CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial. Journal of the National Cancer Institute JNCI, 104(6), pp. 441-451. Oxford University Press 10.1093/jnci/djs125

Regan, Meredith M.; Price, Karen N.; Giobbie-Hurder, Anita; Thürlimann, Beat; Gelber, Richard D. (2011). Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer. Breast cancer research, 2011(13 (3)), p. 209. London: BioMed Central Ltd. 10.1186/bcr2837

Viale, Giuseppe; Regan, Meredith M.; Mastropasqua, Mauro G.; Maffini, Fausto; Maiorano, Eugenio; Colleoni, Marco; Price, Karen N.; Golouh, Rastko; Perin, Tiziana; Brown, R. W.; Kovács, Anikó; Pillay, Komala; Öhlschlegel, Christian; Gusterson, Barry A.; Castiglione-Gertsch, Monica; Gelber, Richard D.; Goldhirsch, Aron; Coates, Alan S. (2008). Predictive Value of Tumor Ki-67 Expression in Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer. Journal of the National Cancer Institute JNCI, 100(3), pp. 207-212. Oxford University Press 10.1093/jnci/djm289

Francis, Prudence; Crown, John; Di Leo, Angelo; Buyse, Marc; Balil, Ana; Andersson, Michael; Nordenskjöld, Bo; Lang, Istvan; Jakesz, Raimund; Vorobiof, Daniel; Gutiérrez, Jorge; Van Hazel, Guy; Dolci, Stella; Jamin, Sophie; Bendahmane, Belguendouz; Gelber, Richard D.; Goldhirsch, Aron; Castiglione-Gertsch, Monica; Piccart-Gebhart, Martine (2008). Adjuvant Chemotherapy With Sequential or Concurrent Anthracycline and Docetaxel: Breast International Group 02–98 Randomized Trial. Journal of the National Cancer Institute JNCI, 100(2), pp. 121-133. Oxford University Press 10.1093/jnci/djm287